DZ3382A1 - THIAZOLIDINEDIONE SALT FOR THE TREATMENT OF SUGAR DIABETES - Google Patents

THIAZOLIDINEDIONE SALT FOR THE TREATMENT OF SUGAR DIABETES

Info

Publication number
DZ3382A1
DZ3382A1 DZ013382A DZ013382A DZ3382A1 DZ 3382 A1 DZ3382 A1 DZ 3382A1 DZ 013382 A DZ013382 A DZ 013382A DZ 013382 A DZ013382 A DZ 013382A DZ 3382 A1 DZ3382 A1 DZ 3382A1
Authority
DZ
Algeria
Prior art keywords
treatment
sugar diabetes
thiazolidinedione
salt
thiazolidinedione salt
Prior art date
Application number
DZ013382A
Other languages
French (fr)
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DZ3382A1 publication Critical patent/DZ3382A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DZ013382A 2000-06-08 2001-06-08 THIAZOLIDINEDIONE SALT FOR THE TREATMENT OF SUGAR DIABETES DZ3382A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0014006.1A GB0014006D0 (en) 2000-06-08 2000-06-08 Novel pharmaceutical
PCT/GB2001/002567 WO2001094344A1 (en) 2000-06-08 2001-06-08 Thiazolidinedione salt for treatment of diabetes mellitus

Publications (1)

Publication Number Publication Date
DZ3382A1 true DZ3382A1 (en) 2001-12-13

Family

ID=9893257

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ013382A DZ3382A1 (en) 2000-06-08 2001-06-08 THIAZOLIDINEDIONE SALT FOR THE TREATMENT OF SUGAR DIABETES

Country Status (23)

Country Link
EP (1) EP1296980A1 (en)
JP (1) JP2003535862A (en)
KR (1) KR20030007918A (en)
CN (1) CN1443186A (en)
AP (1) AP2002002673A0 (en)
AU (1) AU2001264078A1 (en)
BG (1) BG107357A (en)
BR (1) BR0111536A (en)
CA (1) CA2411065A1 (en)
CZ (1) CZ20023966A3 (en)
DZ (1) DZ3382A1 (en)
EA (1) EA200300005A1 (en)
GB (1) GB0014006D0 (en)
HU (1) HUP0301137A3 (en)
IL (1) IL153279A0 (en)
MA (1) MA25753A1 (en)
MX (1) MXPA02012100A (en)
NO (1) NO20025883L (en)
OA (1) OA12284A (en)
PL (1) PL360592A1 (en)
SK (1) SK17142002A3 (en)
WO (1) WO2001094344A1 (en)
ZA (1) ZA200209954B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (en) * 2005-07-22 2007-02-01 Ratiopharm Gmbh New salts of rosiglitazone
WO2008091624A2 (en) * 2007-01-22 2008-07-31 Teva Pharmaceutical Industries Ltd. Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof
EP1956018A1 (en) * 2007-02-06 2008-08-13 Boehringer Ingelheim Pharma GmbH & Co. KG Method of preparing a derivative of benzimidazole
WO2010021745A2 (en) * 2008-08-21 2010-02-25 Teva Pharmaceutical Industries Ltd. Polymorphic forms of rosiglitazone hydrobromide and processes for their preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
GB0014006D0 (en) 2000-08-02
BR0111536A (en) 2003-07-01
CZ20023966A3 (en) 2003-04-16
AP2002002673A0 (en) 2002-12-31
NO20025883L (en) 2003-02-03
JP2003535862A (en) 2003-12-02
EA200300005A1 (en) 2003-04-24
NO20025883D0 (en) 2002-12-06
IL153279A0 (en) 2003-07-06
HUP0301137A2 (en) 2003-08-28
WO2001094344A1 (en) 2001-12-13
ZA200209954B (en) 2003-10-10
PL360592A1 (en) 2004-09-20
AU2001264078A1 (en) 2001-12-17
BG107357A (en) 2003-08-29
OA12284A (en) 2003-11-10
CN1443186A (en) 2003-09-17
MA25753A1 (en) 2003-04-01
CA2411065A1 (en) 2001-12-13
MXPA02012100A (en) 2003-04-25
SK17142002A3 (en) 2003-10-07
KR20030007918A (en) 2003-01-23
EP1296980A1 (en) 2003-04-02
HUP0301137A3 (en) 2005-04-28

Similar Documents

Publication Publication Date Title
MA25820A1 (en) COMBINATIONS OF DIPEPTIDYL PEPTIDASE IV INHIBITORS AND OTHER ANTIDIABETIC AGENTS FOR THE TREATMENT OF DIABETES MELLITUS.
MA25823A1 (en) COMPOSITIONS FOR THE TREATMENT OF WATER.
ATE344253T1 (en) THIAZOLE DERIVATIVES FOR THE TREATMENT OF PPAR-LATED DISEASES
DE60026704D1 (en) (S, S) -Reboxetine for the treatment of chronic pain
FR22C1033I1 (en) Use of dihydroimidazolones for the treatment of dogs
IL158590A0 (en) Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
IS2793B (en) Use of 3-hydroxy-3-methylglutaryl auxiliary enzyme A antacid inhibitors for the manufacture of a medicament for the treatment of diabetes mellitus
MA28583B1 (en) Pyrimidine derivatives for the treatment of abnormal cell growth
MA26951A1 (en) PYRAZOLE DERIVATIVES FOR THE TREATMENT OF VIRAL DISEASES
MA25847A1 (en) COMPOSITION FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION.
FR2882654B1 (en) USE OF DIOSMETIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF THROMBOTIC DISEASES
DZ3382A1 (en) THIAZOLIDINEDIONE SALT FOR THE TREATMENT OF SUGAR DIABETES
FR2891460B1 (en) USE OF AT LEAST ONE COMPOUND OF THE AVERMECTIN FAMILY FOR THE TREATMENT OF OPHTHALMIC DISEASES DUE TO DEMODEX FOLLICULORUM.
FR2786390B1 (en) CORRECTION COTYL FOR USE IN THE TREATMENT OF HIP CONDITIONS
FR2835851B1 (en) COMPOSITION FOR THE TREATMENT OF MAGNESIUM ALLOYS
FR2800614B1 (en) COMPOSITION FOR THE TREATMENT OF RESPIRATORY INFECTIONS
MA25852A1 (en) METHOD FOR THE TREATMENT OF INFLAMMATION.
FR2881130B1 (en) REACTOR FOR THE TREATMENT OF WATER FOR ITS POTABILIZATION
FR2922109B1 (en) PHARMACEUTICAL OR DIETETIC COMPOSITION FOR INHIBITING INTESTINAL ABSORPTION OF SUGAR.
FR2906467B1 (en) USE OF COMPOUNDS FROM THE MILBEMYCIN FAMILY FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS IN MAN
FR2906466B1 (en) USE OF COMPOUNDS FROM THE MILBEMYCIN FAMILY FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS IN MAN
ATE343387T1 (en) S-METHYL-DIHYDRO-ZIPRASIDONE FOR THE TREATMENT OF EYE DISEASES.
FR2849599B1 (en) USE OF KYNURENINE-3-HYDROXYLASE INHIBITORS FOR THE TREATMENT OF DIABETES
FR2806293B1 (en) SCLERAL IMPLANTS FOR THE TREATMENT OF RETINE DISCOLUTION
FR2884716B1 (en) USE OF AZITHROMYCIN FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF OCULAR INFECTIONS